MERS001 MERS-CoV Vaccine Trial (Middle East Respiratory Syndrome Coronavirus)

Tweet about this on TwitterShare on FacebookShare on Google+Share on LinkedInEmail this to someonePrint this page

We are looking for healthy volunteers to take part in a trial testing a new vaccine (ChAdOx1 MERS) against the Middle East Respiratory Syndrome Coronavirus (MERS-CoV), one of the most worrying newly emerging outbreak diseases. If you are aged 18-50 and are in good health you may be eligible to participate. The trial will involve 7 visits over a period of 6 months. Participants will receive up to £335 on completion of the study.

Reimbursement

Participants will receive around £335 within 6 weeks of completion of the study.

Date required

The trial is open now and recruitment is on-going.

Organisation

Jenner Institute, Nuffield Department of Medicine, University of Oxford

Contact

Natalie Lella, Volunteer Recruitment Co-ordinator
www.trialspark.com/trials/MERS-Study
vaccinetrials@ndm.ox.ac.uk
01865 611424

Clinical Trial Registration Details

NCT03399578
clinicaltrials.gov/ct2/show/NCT03399578